Summary. Orally active synthetic oestrogens and progestins were studied in tests to prevent pregnancy in rats. By daily administration the contraceptive effect of ethynyloestradiol and a new oestrogen, 17\g=a\-[3-furyl]-estra-1,3,5(10),7-tetraene-3,17-diol 3-acetate (AY-11483), was potentiated by three progestins, namely, chlormadinone acetate, 6-chloro-3\g=b\,17\g=a\-dihydroxypregn-4,6-dien-20-one diacetate (AY-11440) and medrogestone. AY-11483 given alone, or together with AY-11440, was more potent in preventing ovulation and implantation than ethynyloestradiol alone or in combination with other compounds. Chlormadinone acetate or AY-11440 alone were completely inactive in all the assays. The mode of action of oestrogen or oestrogen and progestin in the prevention of ovulation and implantation is discussed. In the rat, implantation seems more vulnerable to oestrogens than does ovulation.
INTRODUCTION
Recently, Diczfalusy (1968) reviewed the use of various oestrogens and pro¬ gestins and their possible mode of action in blocking pregnancy both in humans and laboratory animals. The present paper reports experiments on the pre¬ vention of pregnancy in rats in which a series of tests was used to study a new oestrogen, AY-11483, and to compare its effects with other known oestrogens and progestins. The chemical and biological properties of AY-11483 were reported earlier (Lefebvre, Marshall, Revesz, Banik & Deghenghi, 1967 No. of rats pregnant 9/10 7/10 6/10 8/10 9/10 10/10 8/10 0/10t 8/10 o/iot o/iot 0/12t Implantations (n t + S.E.) 100 /ig/rat, Groups 2 to 5) given 1 day before pro-oestrus, was effective in preventing ovulation. These oestrogens were only effective if given at the 100 ¿ig dose level over the entire cycle ( the whole of the cycle (Table 3) prevented ovulation. Furthermore, 10^g of either of these oestrogens plus 100/ig of either of these progestins, when given in a single dose 1 day before pro-oestrus, was found inactive (Table 2 ). Partial inhibition of ovulation was achieved with the oestrogen-progestin combinations given over the entire length of the cycle (Table 3) . Of these treatments, it seems that 10^g of AY-11483 alone or in combination with 100 µg of AY-11440 ( Table 4 show that 10 /ig of either ethynyloestradiol or AY-11483 is partially effective in preventing the implantation of ova in mated rats when administered over a period of 5 days (Groups 2 and 4). These two oestrogens were more effective if given in doses of 100 µg on Day 1 (100) Ethynyloestradiol ( (Group 14) . In a subsequent study, we failed to collect ova on Day 5 of pregnancy from the reproductive tract of rats treated daily with AY-11483 (10 µg) and AY-11440 (100 µg) during the preceding 4 days.
Chlormadinone acetate or AY-11440 given in doses up to 2-5 mg was inactive in preventing implantation (Groups 7 to 10).
DISCUSSION
The results presented in this paper demonstrate the anti-fertility effect of a new orally active oestrogen AY-11483 given alone in moderately high doses or in combination with a progestin in lower doses. The new oestrogen was more effective than various other oestrogens given in similar doses (Tables 3 and 4) (Table 4) , although the progestational activity of these two progestins in rabbits is similar (Revesz, Banik & Herr, 1967) . Synergism in anti-ovulatory tests between ethynyloestradiol and chlormadinone acetate in rabbits (Chambón & Veve, 1966) and between ethynyloestradiol and norgestrel in rats (Edgren, Jones & Peterson, 1967) has been reported before and was confirmed in these experiments.
Data obtained from the anti-ovulatory assay (Tables 2 and 3) revealed that a prolonged treatment with oestrogen was more effective in preventing ovula¬ tion than the single dose. Oestrogens could conceivably inhibit the release of both fsh and lh (Dorfman & Dorfman, 1963; McCann & Taleisnik, 1961) and thus prevent ovulation. The other possibility is that oestrogens maintain the life of the corpus luteum. Thus, the progesterone produced by the corpora lutea may act independently, or together with the oestrogen to inhibit the release of lh and block ovulation (Watnick, Gibson, Vinegra & Tolksdorf, 1964) . However, in a subsequent experiment (Tables 2 and 3 ), a 'break¬ through' in ovulation was observed in some rats when 10 µg of ethynyloestradiol or AY-11483 was given daily during the pre-ovulatory period in combination with 100 µg of chlormadinone acetate or AY-11440. Similar effects with oral contraceptives were suggested in human trials (Rudel, Martinez-Manautou & Maquco-Topete, 1965) . Since a single administration of 100 µg of either ethynyloestradiol or AY-11483 did not prevent ovulation (Table 2 ), but pre¬ cluded implantation (Table 4) , it is believed that the process of implantation in rats is more vulnerable to these oestrogens than is ovulation.
The primary contraceptive effect of excessive oestrogen or oestrogen plus progestin in mated rats before nidation was perhaps due to the expulsion of fertilized eggs Pincus, Banik & Jacques, 1964; Bennett, Kendle, Vallance & Vickery, 1966) . Although a potent anti-oestrogenic pro¬ gestin, on the other hand, delays the implantation of eggs (Nutting & Soliman, 1967) , data presented in this paper ( (Psychoyos, 1966; Mayer, 1966) , the expulsion of eggs by AY-11483 alone or with AY-11440 (Table 4) is thought to be the primary mode of action.
The present study indicates that AY-11483 is orally active in preventing pregnancy in rats by interfering with both ovulation and implantation.
